TUMOR NECROSIS FACTOR-ALPHA CACHECTIN ACTIVATES THE O2--GENERATING SYSTEM OF HUMAN-NEUTROPHILS INDEPENDENTLY OF THE HYDROLYSIS OF PHOSPHOINOSITIDES AND THE RELEASE OF ARACHIDONIC-ACID

被引:56
作者
LAUDANNA, C
MIRON, S
BERTON, G
ROSSI, F
机构
[1] Institute of General Pathology, University of Verona, Verona
关键词
D O I
10.1016/0006-291X(90)91946-P
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the mechanisms of transmembrane signalling implicated in the activation of the respiratory burst of adherent neutrophils by tumor necrosis factor-α/cachectin (TNF). The activation of the respiratory burst by TNF is insensitive to pertussis toxin and weakly sensitive to protein kinase C inhibitors. Cytochalasin B and dibutyryl cyclic AMP have an inhibitory effect. The activation of the respiratory burst by TNF takes place in the absence of formation of 3H-inositol phosphates, 32P-phosphatidic acid, and 3H-arachidonic acid. These results demonstrate that the activation of the respiratory burst by an endogenous, physiologic stimulus can be independent of the formation of messengers derived from hydrolysis of phosphoinositides. © 1990.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 26 条
[1]  
BELLAVITE P, 1983, EUR J CLIN INVEST, V13, P363
[2]  
BERKOW RL, 1987, J IMMUNOL, V139, P3783
[5]  
DELLABIANCA V, 1990, IN PRESS J IMMUNOL
[6]   EFFECTS OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA ON HUMAN NEUTROPHIL MIGRATION, RESPIRATORY BURST AND DE-GRANULATION [J].
FERRANTE, A ;
NANDOSKAR, M ;
WALZ, A ;
GOH, DHB ;
KOWANKO, IC .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1988, 86 (01) :82-91
[7]  
FIGARI IS, 1987, BLOOD, V70, P979
[8]   STIMULATION OF THE ADHERENCE OF NEUTROPHILS TO UMBILICAL VEIN ENDOTHELIUM BY HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR [J].
GAMBLE, JR ;
HARLAN, JM ;
KLEBANOFF, SJ ;
VADAS, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8667-8671
[9]  
KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220
[10]  
KOWANATZKI E, 1988, CLIN EXP IMMUNOL, V74, P143